Mandate

Vinge advises Barclays Bank PLC in connection with its establishment in Sweden

November 19, 2013

Vinge has advised Barclays Bank PLC in connection with its establishment in Sweden which included, among other things, extensive contacts with the Swedish Financial Supervisory Authority. Barclays Bank PLC is one of the world’s largest financial services providers and engages in personal banking, credit cards, corporate and investment banking, wealth and investment management. Barclays Bank PLC has an extensive international presence in Europe, the Americas, Africa and Asia and, as a result of its establishment in Sweden, Barclays intends to strengthen its presence in the Nordic region and thereby increase its service offering for existing and potential customers. Barclays Bank PLC’s extensive authorisations for its Swedish operations are set forth on the Swedish Financial Supervisory Authority’s website; www.fi.se.

Vinge’s advice pertained to, among other things, authorisation issues relating to financial services, passporting of existing authorisations within the EEA, anti-money laundering, consumer law, tax law and real estate law. The work was undertaken in consultation with Barclay’s corporate counsel teams in London and Frankfurt.

Vinge’s team consisted of responsible partner Fredrik Wilkens together with a team of financial services specialists including Emma Stuart-Beck, Malin Sund, Helena Håkansson and Sabina Börjesson. In addition, Maria Schultzberg and Ulf Nilsson advised on tax law, Fredrik Gustafsson and Åsa Gotthardsson advised on employment law issues and Martin Folke advised on real estate issues.

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024